If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1993-1995 M.S., Institute of Preventive Medicine, College of Public Health, National Taiwan University
  • 1986-1993 M.D., School of Medicine, College of Medicine, National Taiwan University

Experience

  • 2012.08- Professor, Department of Psychiatry, Taipei Medical University
  • 2009 Chief, Department of Psychiatry, Taipei Medical University-Wan Fang Hospital
  • 2009.08-2012.07 Associate Professor, Department of Psychiatry, Taipei Medical University
  • 2007.08- Assistant Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
  • 2005.02-2009.07 Assistant Professor, Department of Psychiatry, Taipei Medical University
  • 2001 Lecturer, Department of Psychiatry, Taipei Medical University
  • 2000 Staff Psychiatrist, Department of Psychiatry, Taipei Medical University-Wan Fang Hospital
  • 1999 Staff Psychiatrist, Department of Psychiatry, Shin Kong Wu Ho-Su Memorial Hospital
  • 1998 Chief Resident, Taipei City Psychiatric Center
  • 1995 Resident, Taipei City Psychiatric Center

Awards

  • 2005 Shi-Jin Tsai Memorial Award (Young Investigator Award), Taiwanese Society of Psychiatry
  • 2005 Schizophrenia Research Award, Taiwanese Society of Psychiatry
  • 2005 Travel Award, Joint Meeting of the 27th Japanese Society of Biological psychiatry and the 35th Japanese Society of Neuropsychopharmacology, Osaka, Japan
  • 2007 Ta-You Wu Memorial Award (Young Investigator Award), National Science Council
  • 2008 Young Investigator Award, Taipei Medical University
  • 2008 Best Research Award, Taipei Medical University
  • 2010 Young Scientist Travel Award, The 5th Annual Meeting of Japanese Society of Schizophrenia Research, Fukuoka, Japan

Research Interests

  • Psychiatry, Psychopharmacology, Clinical trial

Fingerprint Dive into the research topics where Mong-Liang Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
olanzapine Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences
Antipsychotic Agents Medicine & Life Sciences
Clozapine Medicine & Life Sciences
Fluvoxamine Medicine & Life Sciences
Drug Dose Response Relationship Medicine & Life Sciences
Bipolar Disorder Medicine & Life Sciences
Psychotic Disorders Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2019

Research Output 1997 2019

  • 1569 Citations
  • 22 h-Index
  • 101 Article
  • 1 Chapter

Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: A population-based cohort study

Chen, V. C. H., Lu, M. L., Yang, Y. H., Weng, J. C. & Chang, C. C., Jun 15 2019, In : Journal of Affective Disorders. 253, p. 147-153 7 p.

Research output: Contribution to journalArticle

Hepatitis C
Interferons
Antidepressive Agents
Hepatocellular Carcinoma
Cohort Studies

Exploration of microbiota targets for major depressive disorder and mood related traits

Chung, Y. C. E., Chen, H. C., Chou, H. C. L., Chen, I. M., Lee, M. S., Chuang, L. C., Liu, Y. W., Lu, M. L., Chen, C. H., Wu, C. H., Huang, M. C., Liao, S. C., Ni, Y. H., Lai, M. S., Shih, W. L. & Kuo, P. H., Apr 1 2019, In : Journal of Psychiatric Research. 111, p. 74-82 9 p.

Research output: Contribution to journalArticle

Microbiota
Major Depressive Disorder
Depression
Anxiety
Fats

Homocysteine, rather than age of onset, is a better predictor for cognitive function in older adults with bipolar disorder

Chen, P-H., Liu, H-C., Lu, M-L., Chen, C-H., Chang, C-J., Chiu, W-C., Sun, I-W., Liu, S-I., Tsai, S-Y., Chiu, C-C. & Stewart, R., May 21 2019, In : International Journal of Geriatric Psychiatry.

Research output: Contribution to journalArticle

Homocysteine
Bipolar Disorder
Age of Onset
Cognition
Blood Vessels
Treatment-Resistant Depressive Disorder
Depressive Disorder
Meta-Analysis
Safety
Depression

New use for old drugs: The protective effect of atypical antipsychotics on hepatocellular carcinoma

Chen, V. C. H., Chan, H. L., Hsu, T. C., Lu, M. L., Lee, Y. C., Lee, Y., Siow, J. Y., McIntyre, R. S., Zhou, A. J., Tzang, B. S. & Lee, C. T. C., 2019, In : International Journal of Cancer.

Research output: Contribution to journalArticle

Protective Agents
Antipsychotic Agents
Hepatocellular Carcinoma
Risperidone
Clozapine